Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225089176> ?p ?o ?g. }
- W4225089176 endingPage "e229478" @default.
- W4225089176 startingPage "e229478" @default.
- W4225089176 abstract "<h3>Importance</h3> Increased risk of neurological and psychiatric conditions after traumatic brain injury (TBI) is well-defined. However, cardiovascular and endocrine comorbidity risk after TBI in individuals without these comorbidities and associations with post-TBI mortality have received little attention. <h3>Objective</h3> To assess the incidence of cardiovascular, endocrine, neurological, and psychiatric comorbidities in patients with mild TBI (mTBI) or moderate to severe TBI (msTBI) and analyze associations between post-TBI comorbidities and mortality. <h3>Design, Setting, and Participants</h3> This prospective longitudinal cohort study used hospital-based patient registry data from a tertiary academic medical center to select patients without any prior clinical comorbidities who experienced TBI from 2000 to 2015. Using the same data registry, individuals without head injuries, the unexposed group, and without target comorbidities were selected and age-, sex-, and race-frequency–matched to TBI subgroups. Patients were followed-up for up to 10 years. Data were analyzed in 2021. <h3>Exposures</h3> Mild or moderate to severe head trauma. <h3>Main Outcomes and Measures</h3> Cardiovascular, endocrine, neurologic, and psychiatric conditions were defined based on<i>International Classification of Diseases, Ninth Revision</i>(<i>ICD-9</i>) or<i>International Statistical Classification of Diseases and Related Health Problems, Tenth Revision</i>(<i>ICD-10</i>). Associations between TBI and comorbidities, as well as associations between the comorbidities and mortality, were analyzed. <h3>Results</h3> A total of 4351 patients with mTBI (median [IQR] age, 45 [29-57] years), 4351 patients with msTBI (median [IQR] age, 47 [30-58] years), and 4351 unexposed individuals (median [IQR] age, 46 [30-58] years) were included in analyses. In each group, 45% of participants were women. mTBI and msTBI were significantly associated with higher risks of cardiovascular, endocrine, neurologic, and psychiatric disorders compared with unexposed individuals. In particular, hypertension risk was increased in both mTBI (HR, 2.5; 95% CI, 2.1-2.9) and msTBI (HR, 2.4; 95% CI, 2.0-2.9) groups. Diabetes risk was increased in both mTBI (HR, 1.9; 95% CI, 1.4-2.7) and msTBI (HR, 1.9; 95% CI, 1.4-2.6) groups, and risk of ischemic stroke or transient ischemic attack was also increased in mTBI (HR, 2.2; 95% CI, 1.4-3.3) and msTBI (HR, 3.6; 95% CI, 2.4-5.3) groups. All comorbidities in the TBI subgroups emerged within a median (IQR) of 3.49 (1.76-5.96) years after injury. Risks for post-TBI comorbidities were also higher in patients aged 18 to 40 years compared with age-matched unexposed individuals: hypertension risk was increased in the mTBI (HR, 5.9; 95% CI, 3.9-9.1) and msTBI (HR, 3.9; 95% CI, 2.5-6.1) groups, while hyperlipidemia (HR, 2.3; 95% CI, 1.5-3.4) and diabetes (HR, 4.6; 95% CI, 2.1-9.9) were increased in the mTBI group. Individuals with msTBI, compared with unexposed patients, had higher risk of mortality (432 deaths [9.9%] vs 250 deaths [5.7%];<i>P</i> < .001); postinjury hypertension (HR, 1.3; 95% CI, 1.1-1.7), coronary artery disease (HR, 2.2; 95% CI, 1.6-3.0), and adrenal insufficiency (HR, 6.2; 95% CI, 2.8-13.0) were also associated with higher mortality. <h3>Conclusions and Relevance</h3> These findings suggest that TBI of any severity was associated with a higher risk of chronic cardiovascular, endocrine, and neurological comorbidities in patients without baseline diagnoses. Medical comorbidities were observed in relatively young patients with TBI. Comorbidities occurring after TBI were associated with higher mortality. These findings suggest the need for a targeted screening program for multisystem diseases after TBI, particularly chronic cardiometabolic diseases." @default.
- W4225089176 created "2022-04-30" @default.
- W4225089176 creator A5015090281 @default.
- W4225089176 creator A5018911658 @default.
- W4225089176 creator A5021701327 @default.
- W4225089176 creator A5033424239 @default.
- W4225089176 creator A5038106261 @default.
- W4225089176 creator A5051898729 @default.
- W4225089176 creator A5052169338 @default.
- W4225089176 creator A5056697484 @default.
- W4225089176 creator A5064445072 @default.
- W4225089176 creator A5064893777 @default.
- W4225089176 creator A5068910064 @default.
- W4225089176 creator A5073848713 @default.
- W4225089176 creator A5077876801 @default.
- W4225089176 creator A5077949191 @default.
- W4225089176 creator A5078482348 @default.
- W4225089176 creator A5081238267 @default.
- W4225089176 creator A5083117986 @default.
- W4225089176 creator A5084379444 @default.
- W4225089176 creator A5086215303 @default.
- W4225089176 creator A5086410623 @default.
- W4225089176 date "2022-04-28" @default.
- W4225089176 modified "2023-10-02" @default.
- W4225089176 title "Association of Traumatic Brain Injury With the Risk of Developing Chronic Cardiovascular, Endocrine, Neurological, and Psychiatric Disorders" @default.
- W4225089176 cites W1869362176 @default.
- W4225089176 cites W1950003721 @default.
- W4225089176 cites W2019825045 @default.
- W4225089176 cites W2024763628 @default.
- W4225089176 cites W2034354239 @default.
- W4225089176 cites W2039808631 @default.
- W4225089176 cites W2043813634 @default.
- W4225089176 cites W2128207478 @default.
- W4225089176 cites W2162660365 @default.
- W4225089176 cites W2171433652 @default.
- W4225089176 cites W2306237590 @default.
- W4225089176 cites W2516884459 @default.
- W4225089176 cites W2530557763 @default.
- W4225089176 cites W2568336832 @default.
- W4225089176 cites W2745254987 @default.
- W4225089176 cites W2754554955 @default.
- W4225089176 cites W2801625478 @default.
- W4225089176 cites W2899028782 @default.
- W4225089176 cites W2912370667 @default.
- W4225089176 cites W2919241137 @default.
- W4225089176 cites W2945364506 @default.
- W4225089176 cites W2947669607 @default.
- W4225089176 cites W2966474256 @default.
- W4225089176 cites W2998494373 @default.
- W4225089176 cites W3121404931 @default.
- W4225089176 cites W3128193478 @default.
- W4225089176 cites W3193412069 @default.
- W4225089176 cites W4237447871 @default.
- W4225089176 cites W4238210133 @default.
- W4225089176 doi "https://doi.org/10.1001/jamanetworkopen.2022.9478" @default.
- W4225089176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35482306" @default.
- W4225089176 hasPublicationYear "2022" @default.
- W4225089176 type Work @default.
- W4225089176 citedByCount "34" @default.
- W4225089176 countsByYear W42250891762022 @default.
- W4225089176 countsByYear W42250891762023 @default.
- W4225089176 crossrefType "journal-article" @default.
- W4225089176 hasAuthorship W4225089176A5015090281 @default.
- W4225089176 hasAuthorship W4225089176A5018911658 @default.
- W4225089176 hasAuthorship W4225089176A5021701327 @default.
- W4225089176 hasAuthorship W4225089176A5033424239 @default.
- W4225089176 hasAuthorship W4225089176A5038106261 @default.
- W4225089176 hasAuthorship W4225089176A5051898729 @default.
- W4225089176 hasAuthorship W4225089176A5052169338 @default.
- W4225089176 hasAuthorship W4225089176A5056697484 @default.
- W4225089176 hasAuthorship W4225089176A5064445072 @default.
- W4225089176 hasAuthorship W4225089176A5064893777 @default.
- W4225089176 hasAuthorship W4225089176A5068910064 @default.
- W4225089176 hasAuthorship W4225089176A5073848713 @default.
- W4225089176 hasAuthorship W4225089176A5077876801 @default.
- W4225089176 hasAuthorship W4225089176A5077949191 @default.
- W4225089176 hasAuthorship W4225089176A5078482348 @default.
- W4225089176 hasAuthorship W4225089176A5081238267 @default.
- W4225089176 hasAuthorship W4225089176A5083117986 @default.
- W4225089176 hasAuthorship W4225089176A5084379444 @default.
- W4225089176 hasAuthorship W4225089176A5086215303 @default.
- W4225089176 hasAuthorship W4225089176A5086410623 @default.
- W4225089176 hasBestOaLocation W42250891761 @default.
- W4225089176 hasConcept C118552586 @default.
- W4225089176 hasConcept C120665830 @default.
- W4225089176 hasConcept C121332964 @default.
- W4225089176 hasConcept C126322002 @default.
- W4225089176 hasConcept C187212893 @default.
- W4225089176 hasConcept C201903717 @default.
- W4225089176 hasConcept C2777975874 @default.
- W4225089176 hasConcept C2779159551 @default.
- W4225089176 hasConcept C2781017439 @default.
- W4225089176 hasConcept C61511704 @default.
- W4225089176 hasConcept C71924100 @default.
- W4225089176 hasConcept C72563966 @default.
- W4225089176 hasConceptScore W4225089176C118552586 @default.
- W4225089176 hasConceptScore W4225089176C120665830 @default.
- W4225089176 hasConceptScore W4225089176C121332964 @default.